A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients-Reference-Cited by-同舟云学术

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

Published:2012-04 Issue:15 Volume:59 Page:1350-1361
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

von Birgelen Clemens,Basalus Mounir W.Z.,Tandjung Kenneth,van Houwelingen K. Gert,Stoel Martin G.,Louwerenburg J.(Hans) W.,Linssen Gerard C.M.,Saïd Salah A.M.,Kleijne Miep A.W.J.,Sen Hanim,Löwik Marije M.,van der Palen Job,Verhorst Patrick M.J.,de Man Frits H.A.F.

Funder

Abbott Vascular and Medtronic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents;Kastrati;N Engl J Med,2007

4. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis;Stettler;Lancet,2007

5. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study;Daemen;Lancet,2007

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta‐Analysis of Randomized Controlled Trials;Clinical Cardiology;2024-06

2. Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease;Atherosclerosis;2024-05

3. Complex Percutaneous Coronary Intervention in Patients Unable to Undergo Coronary Artery Bypass Grafting During the COVID-19 Pandemic: Insights From the UK-ReVasc Registry;Journal of Invasive Cardiology;2024-03-06

4. Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting;Cardiovascular Intervention and Therapeutics;2024-02-14

5. Testing a Cloud-Based Model for Active Surveillance of Medical Devices with Analyses of Coronary Stent Safety Using the Data Extraction and Longitudinal Trend Analysis (DELTA) System;Medical Devices: Evidence and Research;2024-02